We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Patients with tricuspid regurgitation showed significant improvements in heart-blood flow one year after receiving Edward Lifesciences’ investigational Pascal transcatheter tricuspid-valve repair system, researchers reported. Read More
Inivata released data at the American Association for Cancer Research Annual Meeting this week demonstrating the potential of its RaDaR assay for the detection of minimal residual disease (MRD) in cancer and its recurrence. Read More
Natera’s Prospera lung donor-derived DNA test has shown positive results in a study assessing rejection and lung-function injury in transplant patients. Read More
Synchron’s Stentrode investigational brain-computer interface device has been found safe and effective in a small study of patients with paralysis caused by amyotrophic lateral sclerosis (ALS). Read More
Roche and Bristol Myers Squibb (BMS) are teaming up to use artificial intelligence (AI) to support the use of two assays in clinical trials for tumor treatment. Read More
ResApp Health has touted positive study results showing its smartphone, audio-based COVID-19 screening test correctly detected the coronavirus in 92 percent of infected people. Read More
Researchers from the University of California San Diego (UCSD) have taken a concert hall sound diffuser and used it to develop an ultrasound device that treats conditions in the brain, such as epilepsy. Read More
Italian diagnostics startup Diadem has released study data indicating that its AlzoSure Confirm blood test can accurately identify patients with early Alzheimer's. Read More
LumiThera has announced positive 13-month findings from its LIGHTSITE III clinical study in which patients with dry age-related macular degeneration (AMD) were treated with the company’s Valeda light delivery system. Read More
San Diego, Calif.-based Biological Dynamics’ Verita blood test detected 96 percent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers in a pilot study, the company said. Read More
Nyxoah’s Genio nerve simulation system significantly reduced the severity of sleep apnea, according to the latest, nonpeer-reviewed results from a human study. Read More
The study results highlight “the potential of the assay to identify patients who may benefit from further early therapeutic intervention,” the company said. Read More